RBF Capital’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
30,000
-14,929
| -33% | -$53.7K | 0.01% | 556 |
|
|
2025
Q1 | $134K | Sell |
44,929
-10,000
| -18% | -$29.9K | 0.01% | 520 |
|
|
2024
Q4 | $183K | Sell |
54,929
-93,522
| -63% | -$312K | 0.01% | 501 |
|
|
2024
Q3 | $497K | Hold |
148,451
| – | – | 0.02% | 407 |
|
|
2024
Q2 | $491K | Hold |
148,451
| – | – | 0.03% | 377 |
|
|
2024
Q1 | $600K | Sell |
148,451
-3,965
| -3% | -$16K | 0.03% | 370 |
|
|
2023
Q4 | $465K | Hold |
152,416
| – | – | 0.03% | 389 |
|
|
2023
Q3 | $457K | Sell |
152,416
-6,233
| -4% | -$18.7K | 0.03% | 368 |
|
|
2023
Q2 | $593K | Sell |
158,649
-56,280
| -26% | -$211K | 0.04% | 338 |
|
|
2023
Q1 | $719K | Sell |
214,929
-53,262
| -20% | -$178K | 0.05% | 285 |
|
|
2022
Q4 | $1.29M | Buy |
+268,191
| New | +$1.29M | 0.1% | 208 |
|